Success Metrics

Clinical Success Rate

87.5%

Based on 7 completed trials

Completion Rate

88%(7/8)

Active Trials

1(11%)

Results Posted

57%(4 trials)

Terminated

1(11%)

Phase Distribution

Ph phase_2

11%

Ph not_applicable

11%

Ph phase_1

11%

Ph phase_3

33%

Ph phase_4

22%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

1(12.5%)

Phase 3Large-scale testing

3(37.5%)

Phase 4Post-market surveillance

2(25.0%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(7)

Terminated(1)

Detailed Status

Completed7

Active, not recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

87.5%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (12.5%)

Phase 21 (12.5%)

Phase 33 (37.5%)

Phase 42 (25.0%)

N/A1 (12.5%)

Trials by Status

active_not_recruiting111%

completed778%

terminated111%

Recent Activity

1 active trials

Showing 5 of 9

active_not_recruitingphase_4

Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection

NCT02656511

completedphase_1

Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

NCT01276600

completedphase_3

National Multicenter Trial Evaluating Two Treatments in Patients with Primary Human Immunodeficiency Virus (HIV-1) Infection

NCT02987530

completed

Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women

NCT03902418

completedphase_2

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

NCT04359095

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT02656511Phase 4

Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection

Active Not Recruiting

NCT01276600Phase 1

Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

Completed

NCT02987530Phase 3

National Multicenter Trial Evaluating Two Treatments in Patients with Primary Human Immunodeficiency Virus (HIV-1) Infection

Completed

NCT03902418

Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women

Completed

NCT04359095Phase 2

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

Completed

NCT02495779Not Applicable

Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV

Completed

NCT01345630Phase 3

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Terminated

NCT00302822Phase 3

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Completed

NCT00244712Phase 4

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9